Simplex Trading
RGC icon

Simplex Trading’s Regencell Bioscience RGC Stock Holding History

Simplex Trading’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09K Sell
1,000
-1,900
-66% -$45.6K ﹤0.01% 8051
2026
Q1 		$73.7K Buy
+2,900
New +$82.1K ﹤0.01% 5439
2025
Q4 		– Sell
-1,100
Closed -$16K – 9824
2025
Q3 		$16K Buy
+1,100
New +$15.8K ﹤0.01% 7549

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Simplex Trading's RGC Position: Q2 2026 in Review

Simplex Trading opened a new position in Regencell Bioscience (RGC) in Q2 2026: 1,717 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #7660 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RGC as recently as Q3 2025.

Simplex Trading first reported a position in RGC in Q3 2025 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Simplex Trading held 1,717 shares of Regencell Bioscience worth $10.5K as of Q2 2026.
  • Regencell Bioscience was a new Simplex Trading position in Q2 2026.
  • Regencell Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7660 holding.
  • Simplex Trading first reported a position in Regencell Bioscience in Q3 2025 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.